Martin Kerschensteiner

Martin Kerschensteiner is a Professor at the Institute of Clinical Neuroimmunology within the Biomedical Center at Ludwig Maximilian University of Munich, where he serves as Director. His work bridges clinical neuroimmunology and mechanistic neuroscience in neurodegenerative diseases.

• Research focuses on immune-mediated damage in multiple sclerosis (MS), including axon degeneration, synapse loss, and microglia activation.
• Key collaborations span the University Hospital and LMU Biomedical Center, emphasizing translational approaches to MS treatment.

Research Interests: Dr. Kerschensteiner investigates how infiltrating immune cells damage neurons and oligodendrocytes in MS, driving irreversible functional deficits. His team explores calcium signaling, mitochondrial dynamics, and myelin degeneration mechanisms to develop neuroprotective therapies.

Publications highlight his contributions to understanding axonal transport deficits, myelinosome formation, and reversible axon damage in MS models. These works integrate advanced imaging and molecular analysis to uncover disease progression pathways.

Students: He has mentored researchers such as Yves Carpentier Solorio, Carla Ares Carral, and Dr. Aleksandra Mezydlo, covering diverse aspects of MS pathology and neuroinflammation.